Emerging Therapies: Phase 3 Efficacy & Safety Data
- JAK-STAT inhibitors: oral and topical
- JAK-STAT inhibitors vs dupilumab
- IL-13 antagonists
- IL-31 antagonists
Information
- Show
- Published1 November 2021 at 15:16 UTC
- Length17 min
- Season1
- Episode5
- RatingClean